Mycophenolate Mofetil Tablet Generics Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 250 mg, 500 mg
Reference Brands: CellCept® (US and EU), Myfortic® (US and EU)
Category:
Nephrology
Mycophenolate Mofetil Tablets are immunosuppressive medications used in nephrology to prevent organ rejection in kidney transplant patients.
Mycophenolate Mofetil Tablet Generics is available in Tablet
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Mycophenolate Mofetil Tablet Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Mycophenolate Mofetil Tablet Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Mycophenolate Mofetil Tablets are immunosuppressive medications widely used in nephrology to prevent organ rejection in kidney transplant patients. This effective medication works by inhibiting immune system cells, thereby reducing the risk of transplant rejection. Marketed under leading brands such as CellCept® (US and EU) and Myfortic® (US and EU), Mycophenolate Mofetil is available in tablet form and is often used in combination with other immunosuppressants like cyclosporine and prednisone. It is essential for managing transplant patients' health and ensuring long-term graft survival. Pharma B2B buyers can rely on Mycophenolate Mofetil for high-quality, trusted nephrology solutions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing